检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈伟[1] 翁志梁[1] 余凯远[3] 李叶平[1] 邓哲宪[1] 吴海涵[1] 吴秀玲[2] 李澄棣[1]
机构地区:[1]温州医学院附属第一医院泌尿外科,浙江省温州市325000 [2]温州医学院附属第一医院病理科,浙江省温州市325000 [3]温州医学院附属第二医院泌尿外科
出 处:《中华老年医学杂志》2008年第11期815-817,共3页Chinese Journal of Geriatrics
摘 要:目的研究非那雄胺在晚期前列腺癌间歇性雄激素阻断(IAB)治疗间隙期的应用是否能延缓晚期前列腺癌的疾病进展。方法87例晚期前列腺癌患者分2组,A组49例行单纯IAB治疗,B组38例在IAB治疗的基础上间歇期采用非那雄胺治疗。比较2组患者的疾病治疗周期和疾病进展时间。结果A组患者共完成89个治疗周期,平均治疗周期为(12.8±5.4)个月,其中治疗期为(6.6±3.5)个月,间歇期为(7.1±4.8)个月;B组患者共完成85个治疗周期,平均治疗周期为(15.3±5.9)个月,其中治疗期为(6.9±3.2)个月,间歇期为(9.2±3.9)个月;B组治疗周期和间歇期长度大于A组(P=0.0428,P=0.03)。B组3年疾病进展率(28.4±2.7)%,低于A组的(34.8±3.5)%(P=0.0350)。结论非那雄胺在晚期前列腺癌间歇性IAB间隙期的应用能延缓晚期前列腺癌的疾病进展。Objective To investigate the finasteride application during the off cycle of intermittent androgen blockade (IAB) in patients with advanced prostate cancer treated with IAB. Methods Eighty-seven patients with advanced prostate cancer were divided into two groups: forty nine patients received IAB (group A), and thirty eight patients underwent IAB and finasteride during the off-cycle of lAB (group B). The time of treatment cycle and the time to disease progression were compared between the two groups. Results The patients in group A completed 89 treatment cycles and the mean cycle length was (12.8 ±5.4) months [treatmcnt time and non-treatment time were (6.6±3.5) months and (7.1±4.8) months, respectively]. The patients in group B completed 85 cycles and the mean cycle length was (15.3 ±5.9) months [treatment time and non-treatment time were (6.9±3.2) months and (9.2±3.9) months, respectively]. There was a significant difference between group A and B in the mean cycle length and the non treatment time (P 0. 0428 ,P= 0.03). The 3-year progression rate was(34.8 ± 3.5)% in group A and(28.4 ± 2.7)% in groups B (P= 0. 035). Conclusions The application of finasteride during the off-cycle of IAB in patients with advanced prostate cancer treated with intermittent androgen blockade (IAB) can delay progression of advanced prostate cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222